Cargando…
Patients With Ischemic Core ≥70 ml Within 6 h of Symptom Onset May Still Benefit From Endovascular Treatment
Background: Large core is associated with poor outcome in acute ischemic stroke (AIS) patients. It is unclear whether endovascular treatment (EVT) could bring benefits to patients with core volume ≥70 ml before treatment. We aimed to compare the impact of EVT with intravenous thrombolysis (IVT) on t...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6230959/ https://www.ncbi.nlm.nih.gov/pubmed/30455665 http://dx.doi.org/10.3389/fneur.2018.00933 |
_version_ | 1783370147436691456 |
---|---|
author | Chen, Zhicai Zhang, Ruiting Zhou, Ying Gong, Xiaoxian Zhang, Meixia Shi, Feina Yu, Xinfeng Lou, Min |
author_facet | Chen, Zhicai Zhang, Ruiting Zhou, Ying Gong, Xiaoxian Zhang, Meixia Shi, Feina Yu, Xinfeng Lou, Min |
author_sort | Chen, Zhicai |
collection | PubMed |
description | Background: Large core is associated with poor outcome in acute ischemic stroke (AIS) patients. It is unclear whether endovascular treatment (EVT) could bring benefits to patients with core volume ≥70 ml before treatment. We aimed to compare the impact of EVT with intravenous thrombolysis (IVT) on the outcome in patients with core volume ≥70 ml. Methods: We included consecutive anterior circulation AIS patients who underwent MR or CT perfusion within 6 h post stroke onset, which revealed a core ≥70 ml before reperfusion therapy. Good outcome was defined by modified Rankin Scale of 0 to 2 at 90-day. Reperfusion was defined as a reduction in hypoperfusion volume of ≥70% between baseline and 24 h. Results: One hundred four patients were included. Among them, 76 received IVT only, and 28 received EVT. After adjusting for age, NIHSS score, baseline core volume and onset to imaging time, patients in EVT group were more likely to achieve good outcome compared to IVT patients (OR, 3.875; 95% Cl 1.068–14.055, p = 0.039). More patients in EVT group achieved recanalization (84.0 vs. 58.5%, p = 0.027) and reperfusion (66.7 vs. 33.3%, p = 0.010) than in IVT group. Reperfusion also independently predicted good outcome (OR, 7.718; 95% Cl 1.713-34.772, p = 0.008). All patients with good outcome achieved recanalization at 24 h. Conclusions: Our data indicated that patients with core volume ≥70 ml might still benefit from EVT, which was related to its high reperfusion rate. |
format | Online Article Text |
id | pubmed-6230959 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-62309592018-11-19 Patients With Ischemic Core ≥70 ml Within 6 h of Symptom Onset May Still Benefit From Endovascular Treatment Chen, Zhicai Zhang, Ruiting Zhou, Ying Gong, Xiaoxian Zhang, Meixia Shi, Feina Yu, Xinfeng Lou, Min Front Neurol Neurology Background: Large core is associated with poor outcome in acute ischemic stroke (AIS) patients. It is unclear whether endovascular treatment (EVT) could bring benefits to patients with core volume ≥70 ml before treatment. We aimed to compare the impact of EVT with intravenous thrombolysis (IVT) on the outcome in patients with core volume ≥70 ml. Methods: We included consecutive anterior circulation AIS patients who underwent MR or CT perfusion within 6 h post stroke onset, which revealed a core ≥70 ml before reperfusion therapy. Good outcome was defined by modified Rankin Scale of 0 to 2 at 90-day. Reperfusion was defined as a reduction in hypoperfusion volume of ≥70% between baseline and 24 h. Results: One hundred four patients were included. Among them, 76 received IVT only, and 28 received EVT. After adjusting for age, NIHSS score, baseline core volume and onset to imaging time, patients in EVT group were more likely to achieve good outcome compared to IVT patients (OR, 3.875; 95% Cl 1.068–14.055, p = 0.039). More patients in EVT group achieved recanalization (84.0 vs. 58.5%, p = 0.027) and reperfusion (66.7 vs. 33.3%, p = 0.010) than in IVT group. Reperfusion also independently predicted good outcome (OR, 7.718; 95% Cl 1.713-34.772, p = 0.008). All patients with good outcome achieved recanalization at 24 h. Conclusions: Our data indicated that patients with core volume ≥70 ml might still benefit from EVT, which was related to its high reperfusion rate. Frontiers Media S.A. 2018-11-05 /pmc/articles/PMC6230959/ /pubmed/30455665 http://dx.doi.org/10.3389/fneur.2018.00933 Text en Copyright © 2018 Chen, Zhang, Zhou, Gong, Zhang, Shi, Yu and Lou. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Neurology Chen, Zhicai Zhang, Ruiting Zhou, Ying Gong, Xiaoxian Zhang, Meixia Shi, Feina Yu, Xinfeng Lou, Min Patients With Ischemic Core ≥70 ml Within 6 h of Symptom Onset May Still Benefit From Endovascular Treatment |
title | Patients With Ischemic Core ≥70 ml Within 6 h of Symptom Onset May Still Benefit From Endovascular Treatment |
title_full | Patients With Ischemic Core ≥70 ml Within 6 h of Symptom Onset May Still Benefit From Endovascular Treatment |
title_fullStr | Patients With Ischemic Core ≥70 ml Within 6 h of Symptom Onset May Still Benefit From Endovascular Treatment |
title_full_unstemmed | Patients With Ischemic Core ≥70 ml Within 6 h of Symptom Onset May Still Benefit From Endovascular Treatment |
title_short | Patients With Ischemic Core ≥70 ml Within 6 h of Symptom Onset May Still Benefit From Endovascular Treatment |
title_sort | patients with ischemic core ≥70 ml within 6 h of symptom onset may still benefit from endovascular treatment |
topic | Neurology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6230959/ https://www.ncbi.nlm.nih.gov/pubmed/30455665 http://dx.doi.org/10.3389/fneur.2018.00933 |
work_keys_str_mv | AT chenzhicai patientswithischemiccore70mlwithin6hofsymptomonsetmaystillbenefitfromendovasculartreatment AT zhangruiting patientswithischemiccore70mlwithin6hofsymptomonsetmaystillbenefitfromendovasculartreatment AT zhouying patientswithischemiccore70mlwithin6hofsymptomonsetmaystillbenefitfromendovasculartreatment AT gongxiaoxian patientswithischemiccore70mlwithin6hofsymptomonsetmaystillbenefitfromendovasculartreatment AT zhangmeixia patientswithischemiccore70mlwithin6hofsymptomonsetmaystillbenefitfromendovasculartreatment AT shifeina patientswithischemiccore70mlwithin6hofsymptomonsetmaystillbenefitfromendovasculartreatment AT yuxinfeng patientswithischemiccore70mlwithin6hofsymptomonsetmaystillbenefitfromendovasculartreatment AT loumin patientswithischemiccore70mlwithin6hofsymptomonsetmaystillbenefitfromendovasculartreatment |